SBRT Archives – Beacon Medical Interchange

Dr. Brendon Stiles (Pt 2): Evolving Standards and Open Controversies in Thoracic Surgery for Lung Cancer

Thoracic surgeon Brendon Stiles, MD, speaks with host Jack West about alternatives to open surgery for smaller lung cancers, which patients with locally advanced NSCLC should undergo surgery, and whether we should aim to “downstage” patients with marginally resectable or unresectable lung cancer. (22:56)

Dr. Brendon Stiles (Pt 1): Childhood on the Farm, the Intellectual and Personal Call to Fight Lung Cancer, and Engaging in MedTwitter “Fight Club”

Host Jack West speaks with cardiothoracic surgeon Brendon Stiles, MD, who describes his path from being raised on a farm in rural VA to cancer research and surgery in NYC, & how debating medicine outside of your echo chamber raises everyone’s game. (22:42)

Dr. David Palma (Pt 2): Controversies and Open Questions in Radiation Oncology

Dr. Jack West & Dr. David Palma, expert radiation oncologist in London, Ontario, discuss challenges in delivering radiation in Canada as well debates in radiation oncology care ranging from proton beam radiation to SBRT for oligometastatic NSCLC. (31:07)

Dr. Jack West on New Data Combining Radiation with Immunotherapy in Advanced NSCLC: A Brief Critical Review

Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC. (18:00)

Dr. Puneeth Iyengar (Pt 1): The Appeal of Entering Radiation Oncology, & How the Field is Evolving

Dr. Puneeth Iyengar talks with Dr. Jack West about growing up Indian in Louisiana, his training path from Boston to New York before returning to Texas, his entry into radiation oncology, & how the field is adapting to changes in cancer care. (26:58)

Dr. Greg Riely (Pt 2): Should local ablation therapy in oligometastatic or oligoprogressing cancer be incorporated into routine practice?

Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice. (28:11)

Overall Survival Benefit for Local Ablative Therapy as Consolidation for Oligometastatic Stage IV NSCLC: Where Does it Fit in Practice Now? (BMIC-070)

Dr. Jack West describes recently updated results of a small randomized trial of consolidation local ablative therapy (LAT) for oligometastatic advanced NSCLC after initial systemic therapy & considers whether these results should shape clinical practice. (9:52)

Download MP3 Audio Version

Local Therapy for Advanced NSCLC: Revising Outdated Principles for Selected Patients (BMIC-062)

Dr. Jack West reviews general principles for how local therapies are increasingly appropriate for selected patients with advanced NSCLC, whether at initial management, for limited progression on systemic therapy, or as local consolidation therapy. (15:36)